Select Publications
Select Publications
December, 2025
Gorringe A, Cavell B, Beard F, Tsukada K, Otsuka N, Fu P, Moosa F, Fabianova K, Rodrigues C, Bouchez V, Toubiana J, Brisse S, Dalby T, He Q, Campbell H, Hozbor D, Hariri S, Pawloski L, Scanlon K, Edwards K. Global Incidence of Pertussis After the COVID-19 Pandemic. JAMA Network Open. 2025 Dec 1. PMID: 41324955
November, 2025
Li G, Lou Y, Ma J, Cheng L, Yu H, Tsahouridis O, He X, Funaki M, Ahodantin J, Bi W, Chen J, Fan X, Sharaf S, Goonetilleke N, Jones RB, Kottilil S, Mathur P, and Su L. Depletion of pDCs rescues HIV-reactive stem-like CD8 T cells during chronic HIV-1 infection. Sci Transl Med, 2025 Nov 5. PMID: 41191775
October, 2025
Weston S, Baracco L, Taylor L, Scott AJ, Kumar G, Shapiro P, MacKerell AD Jr, Frieman MB. The mammalian SKI complex is a broad-spectrum antiviral drug target that upregulates cellular cholesterol to inhibit viral replication. Journal of Virology. 2025 Oct 23. PMID: 40928250
Sadik, M., Moin, I., Ullah, S., Krusenstjerna, A.C., Gonin, M., Goley, E.D., Rahman, M.S., Voss, O.H. Pathogenic rickettsiae encode a secreted lipase that facilitates intracytosolic colonization in host cells. PLoS One. 2025 Oct 8. PMID: 41061002
Kumar, A, Bukowski, A, Carbonetti, NH. Myeloid cell-specific type I IFN signaling mediates age-dependent inflammation and protection in Bordetella pertussis infection. Infection and Immunity. 2025 Oct 14. PMID: 40980929
Parrish KM, First N, Kamanova J, Williams TL, Johnson S, King J, Scanlon KM, Azouz NP, Mattoo S, Skerry C, Gestal MC. The Bordetella T3SS effector BteA targets host eosinophil-epithelial signalling to promote IL-1Ra expression and persistence. Communications Biology. 2025 Oct 20. PMID: 41116045
September, 2025
Marnin L, Valencia LM, Bogale HN, Laukaitis-Yousey HJ, Rolandelli A, Rodrigues Ferraz C, O'Neal AJ, Schmitter-Sánchez AD, Bencosme Cuevas E, Nguyen T-T, Leal Galvan B, Rickert DM, Mendes MT, Samaddar S, Butler LR, Singh N, Cabrera Paz FE, Wu-Chuang A, Oliver JD, Jameson JM, Munderloh UG, Oliva Chávez AS, Mulenga A, Park S, Serre D, Pedra JHF. Tick extracellular vesicles alter epidermal keratinocyte function. J Invest Dermatol. 2025 Sept 5. PMID: 40915408
El Zowalaty ME, Taylor LJ, Son Y, Lee H, Rubrum AM, Webby RJ, Bustin SA, Young SG, Lee S-H, Lee D-H, Frieman MB. Discovery, phylogenetic, and comparative genomic analysis of novel avian gamma coronaviruses identified in feral pigeons (Columba livia domestica). Journal of Virology. 2025 Sep 23. PMID: 40833823
August, 2025
Rach D, Hsu H, Nampota-Nkomba N, Mvula G, Mkandawire FA, Nyirenda ON, Hritzo B, Cioetto Mazzabò L, Degiacomi G, Boldrin F, Manganelli R, Buchwald AG, Toapanta FR, Sztein MB, Laufer MK, Lyke KE*, Cairo C*. Cord Blood Innate-like T cell responses in neonates born to healthy women and women living with HIV. Frontiers in Immunology. 2025 Aug 22. PMID: 40918102
July, 2025
Flajnik MF, Stanfield RL, Verissimo A, Neely HR, Muñoz-Mérida A, Criscitiello MF, Wilson IA, Ohta Y. Origin of immunoglobulins and T cell receptors: A candidate gene for invasion by the RAG transposon. Science Advances. 2025 July 4. PMID: 40614193
June, 2025
Voss OH, Moin I, Gaytan H, Sadik M, Ullah S, Rahman MS. Phosphatidylserine-binding receptor, CD300f, on macrophages mediates host invasion of pathogenic and non-pathogenic rickettsiae. Infection & Immunity. 2025 Jun 10. PMID: 40310290
May, 2025
Henrikson DE, Ahmed H, Tasumi S, Gokara M, Feng C, Abernathy K, Iqbal M, Bianchet MA, Vasta GR. A "proto" type galectin expressed in striped bass (Morone saxatilis) tissues is released to epidermal mucus and binds to bacterial and mucus glycans. Frontiers in Cellular & Infection Microbiology. 2025 May 14. PMID: 40438240
Nanjaiah H and Moudgil KD. Pristimerin inhibits the progression of antibody-induced autoimmune arthritis. Scandinavian Journal of Rheumatology. 2025 May. PMID: 39530865
March, 2025
Prantner DJ, Vogel SN. Intracellular methylglyoxal accumulation in classically activated mouse macrophages is mediated by HIF-1a. Journal of Leukocyte Biology. 2025 Mar 14. PMID: 39360990
February, 2025
Shirey KA, Joseph J, Coughlan L, Nijhuis H, Varley AW, Blanco JCG, Vogel SN. An adenoviral vector encoding an inflammation-inducible antagonists, HMGB1 Box A: A novel therapeutic approach to inflammatory diseases. mBio. 2025 Feb 5. PMID: 39699172
Kumar, A, Johnson, D, Bukowski, A, Noto, MJ, Carbonetti, NH. Interferon lambda signaling in neutrophils enhances the pathogenesis of Bordetella pertussis infection. Journal of Leukocyte Biology. 2025 Feb 13. PMID: 39302155
January, 2025
Iqbal M, Feng C, Zong G, Wang LX, and Vasta GR. Galectin-3 disrupts tight junctions of airway epithelial cell monolayers by inducing expression and release of matrix metalloproteinases upon influenza A infection. Glycobiology. 2025 Jan 13. PMID: 39569730 (selected as Editor's Choice)
Select Research Highlights
Select Research Highlights
2025
Book: “The multitasking molecular chaperone Hsp60. Structure, function, and impact on health and disease.” Authored/Edited by Francesco Cappello, Everly Conway de Macario, Alberto J. L. Macario. Academic Press (an Imprint of Elsevier), London, UK; San Diego, CA; and Cambridge, MA, USA, 2025. 310 pp. ISBN: 978-0-443-23996-0. Copyright 2025 Elsevier Inc.
Chapter: Russ, KG, DasSarma, S, Gilden, R, Cloeren, M, Piermattei, W, Patel, ST, Canty, T, Gupta, S and Michalopoulos, LTM. Creating an Interprofessional Consortium on Climate and Health for Higher Education as a Step Toward a Sustainable Future. In World Sustainability Series. North American and European Perspectives on Sustainability in Higher Education. Series Ed. Walter Leal Filho. April 03, 2025
Patent: Broad Spectrum Antiviral Compounds Targeting the SKI Complex, Application Number#. 17/616,586. Matthew Frieman, Alex MacKerell and Stuart Weston
2024
Provisional Patent Application: An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A as a therapeutic for inflammatory diseases; S. Vogel and J.C.G. Blanco. Provisional Patent, UMB docket no: SV-2024-064 (PR2); application number 63/721,755 (11/20/24)
Provisional Patent Application: Inducible HMGB1 antagonist for mitigating local and systemic inflammation; S. N. Vogel and J. C. G. Blanco. Provisional Patent, UMB Docket No: SV-2024-064 (PR); Application Number: 63/680,304 (8/8/24)
Patent: Methods for Decreasing Influenza-induced Lethality using Gastrin Releasing Peptide (GRP) or Gastrin Releasing Peptide Receptor (GRPR) Antagonists. S. N. Vogel, K. A. Shirey, and Frank Cuttitta. PCT Patent Application Number PCT/US2019/050312 (filed: 9/10/19). European Patent Application number: 19 859 381.6 European patent No. 3849604 (Issued May 1, 2024; Expires Sept. 10, 2039) Validated in France, Germany, UK
Honor: Karen Scanlon was elected to Chair of the International Bordetella Society
2023
Honor: Matthew Frieman received endowed Professorship from Marco and Debbie Chacon titled "The Alicia and Yaya Professorship in Viral Pathogen Research"
2021
Patent: Central nervous system homing peptides and uses thereof. Awarded a U.S. patent, Kamal D. Moudgil and Rakeshchandra R Meka. November 2021.
2020
Patent: Compositions and Vaccines Comprising Vesicles and Methods of Using the Same. Phillip DeShong, Daniel Stein, Lenea Stocker, Katharina Richard, and Stefanie Vogel. US Patent Number: 10,017,545; issued July 10, 2018; expiration date: 6/3/2034. Second patent issued: US Patent Number 10,711,043; issued July 14, 2020; expiration date: June 3, 2034.